Strategies for bioresource collection in obstetrics: the experience of the "Genofund" biobank

The article highlights the experience of the "Genofund" biobank of the Ott Research Institute of Obstetrics, Gynecology and Reproductology in bioresource collection in modern obstetrics. To create different types of collections, the following different biobanking strategies were formulated for the first time: cross-sectional and longitudinal (dynamic). Definitions are given for these approaches. The most significant advantages and disadvantages of each of them are noted. Examples of pilot studies conducted on the platform of a bioresource collection created using the complex longitudinal biobanking are given. This approach made it possible to demonstrate, using the example of microRNA analysis, the potential of studying the physiological changes during pregnancy at the present stage, as well as the prospects for finding early predictors of pregnancy complications.

1. Tan EK, Tan EL. Alterations in physiology and anatomy during pregnancy. Best Pract Res Clin Obstet Gynaecol. 2013;27(6): 791-802. doi:10.1016/j.bpobgyn.2013.08.001.

2. Schreiber K, Graversgaard C, Hunt BJ, et al. Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people. Lancet Rheumatol. 2024;6(8): e560-72. doi:10.1016/S2665-9913(24)00118-8.

3. Gomez-Lopez N, Romero R, Hassan SS, et al. The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study. Front Immunol. 2019;10:2863. doi:10.3389/ fimmu.2019.02863.

4. Chen J, Tian R, Zou Z, et al. Longitudinal study of multidimensional factors influencing maternal and offspring health outcomes: a study protocol. BMC Pregnancy Childbirth. 2023;23(1):466. doi:10.1186/s12884-023-05785-1.

5. Mavreli D, Theodora M, Kolialexi A. Known biomarkers for monitoring pregnancy complications. Expert Rev Mol Diagn. 2021; 21(11):1115-7. doi:10.1080/14737159.2021.1971078.

6. Lin W, Teng S-W, Lin T-Y, et al. Combinatorial Analysis of Circulating Biomarkers and Maternal Characteristics for Preeclampsia Prediction in the First and Third Trimesters in Asia. Diagnostics. 2022;12(7):1533. doi:10.3390/diagnostics12071533.

7. Liu Y, Li DY, Bolatai A, Wu N. Progress in Research on Biomarkers of Gestational Diabetes Mellitus and Preeclampsia. Diabetes Metab Syndr Obes. 2023;16:3807-15. doi:10.2147/DMSO.S433179.

8. Maltseva AR, Illarionov RA, Vashukova ES, et al. Inventory and quality control of biosample collection from pregnant women at different gestational ages to search for early biomarkers of pregnancy complications. Cardiovascular Therapy and Prevention. 2023;22(11):3740. (In Russ.) doi:10.15829/1728-8800-2023-3740.

9. Vashukova ES, Kozyulina PY, Illarionov RA, et al. High-Throughput Sequencing of Circulating MicroRNAs in Plasma and Serum during Pregnancy Progression. Life (Basel). 2021;11(10):1055. doi:10.3390/life11101055.

10. Illarionov RA, Pachuliia OV, Vashukova ES, et al. Plasma miRNA Profile in High Risk of Preterm Birth during Early and Mid-Pregnancy. Genes (Basel). 2022;13(11):2018. doi:10.3390/genes13112018.